Baseline <scp>FIB</scp> ‐4 May Be a Risk Factor of Recurrence After <scp>SBRT</scp> in Patients With <scp>HBV</scp> ‐Related Small <scp>HCC</scp>
Baseline FIB-4 is a risk factor for recurrence after SBRT in patients with HBV-related HCC, and the predictive threshold for FIB-4 is higher in patients with cirrhosis. For patients who received radiotherapy, postoperative FIB-4 levels are elevated.
Authors
- Zhan Zeng (ORCID: https://orcid.org/0000-0001-7342-6916)
- Yanyan Yu (ORCID: https://orcid.org/0000-0003-2839-0541)
- Ning Lin (ORCID: https://orcid.org/0000-0003-0440-4304)
- Xiaoyuan Xu (ORCID: https://orcid.org/0000-0002-1759-4330)
- Wengang Li (ORCID: https://orcid.org/0000-0002-6980-1776)
- Yifan Han (ORCID: https://orcid.org/0000-0002-5833-069X)
- Hongyu Chen (ORCID: https://orcid.org/0000-0002-9547-5417)
Institutions
- Peking University (CN)
- Chinese PLA General Hospital (CN)
- Peking University First Hospital (CN)
Publication Details
- Journal
- Cancer Medicine
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1002/cam4.70535
- Citations
- 2
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 2.64
Funders
- Beijing Municipal Science and Technology Commission